These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 37239077)

  • 81. A pilot study on neurological manifestations and antibodies against antigens in children with hematological and other cancers.
    Polizzi A; Ruggieri M; Clover L; La Spina M; Pulvirenti A; Amyes E; Vincent A
    Eur J Paediatr Neurol; 2013 Jan; 17(1):97-101. PubMed ID: 22889753
    [TBL] [Abstract][Full Text] [Related]  

  • 82. SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques.
    Vabanesi M; Pinto AL; Vogrig A; Goncalves D; Rogemond V; Joubert B; Fabien N; Honnorat J; Muñiz-Castrillo S
    J Neurol; 2023 Mar; 270(3):1691-1701. PubMed ID: 36512064
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Paraneoplastic neurological syndromes.
    Iorio R; Spagni G; Masi G
    Semin Diagn Pathol; 2019 Jul; 36(4):279-292. PubMed ID: 31253539
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Paraneoplastic neurologic syndrome: A practical approach.
    Kannoth S
    Ann Indian Acad Neurol; 2012 Jan; 15(1):6-12. PubMed ID: 22412264
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Paraneoplastic neurological syndromes: general treatment overview.
    Viaccoz A; Honnorat J
    Curr Treat Options Neurol; 2013 Apr; 15(2):150-68. PubMed ID: 23436113
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging.
    Opalińska M; Sowa-Staszczak A; Wężyk K; Jagiełła J; Słowik A; Hubalewska-Dydejczyk A
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329862
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
    Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
    J Biosci; 2021; 46():. PubMed ID: 33709965
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Paraneoplastic neurological syndromes (PNS) caused by occult breast cancer and metastatic carcinoma of the lymph node.
    Gong J; Zhang Y; Huang Y; Yin W; Zhang W; Feng J; Wang S; Wu X
    Eur J Gynaecol Oncol; 2015; 36(4):485-7. PubMed ID: 26390710
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Paraneoplastic neurological disorders.
    Blaes F; Tschernatsch M
    Expert Rev Neurother; 2010 Oct; 10(10):1559-68. PubMed ID: 20925471
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Paraneoplastic encephalitis: clinically based approach on diagnosis and management.
    Vaišvilas M; Ciano-Petersen NL; Macarena Villagrán-García MD; Muñiz-Castrillo S; Vogrig A; Honnorat J
    Postgrad Med J; 2023 Apr; ():. PubMed ID: 37036000
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.
    Farina A; Villagrán-García M; Vogrig A; Zekeridou A; Muñiz-Castrillo S; Velasco R; Guidon AC; Joubert B; Honnorat J
    Lancet Neurol; 2024 Jan; 23(1):81-94. PubMed ID: 38101905
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors.
    Jean MJ; Samkoff L; Mohile N
    Curr Treat Options Oncol; 2024 Jan; 25(1):42-65. PubMed ID: 38198120
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Paraneoplastic syndromes in olfactory neuroblastoma.
    Kunc M; Gabrych A; Czapiewski P; Sworczak K
    Contemp Oncol (Pozn); 2015; 19(1):6-16. PubMed ID: 26199564
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Clinical features and treatment of paraneoplastic neurological syndrome associated with small cell lung cancer].
    Zhou L; Guan H; Liu H; Zhu Y; Peng B; Li S; Cui L
    Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(37):3023-6. PubMed ID: 26814083
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Neuropathy associated with paraneoplastic neurological syndrome].
    Mitsui Y; Kusunoki S
    Brain Nerve; 2010 Apr; 62(4):387-93. PubMed ID: 20420179
    [TBL] [Abstract][Full Text] [Related]  

  • 96. What to expect from paraneoplastic syndromes of the nervous system in uterine cancer: A review of the literature.
    Svarna A; Liontos M; Reppas G; Fiste O; Andrikopoulou A; Dimopoulos MA; Zagouri F
    Gynecol Oncol Rep; 2023 Feb; 45():101136. PubMed ID: 36703705
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective.
    Ndondo AP; Eley B; Wilmshurst JM; Kakooza-Mwesige A; Giannoccaro MP; Willison HJ; Cruz PMR; Heckmann JM; Bateman K; Vincent A
    Front Immunol; 2022; 13():833548. PubMed ID: 35356001
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Autoimmune and paraneoplastic movement disorders: An update.
    Baizabal-Carvallo JF; Jankovic J
    J Neurol Sci; 2018 Feb; 385():175-184. PubMed ID: 29406902
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.
    Giometto B; Grisold W; Vitaliani R; Graus F; Honnorat J; Bertolini G;
    Arch Neurol; 2010 Mar; 67(3):330-5. PubMed ID: 20212230
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers.
    Ma J; Wang A; Jiang W; Ma L; Lin Y
    Thorac Cancer; 2021 Aug; 12(16):2265-2270. PubMed ID: 34242487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.